Edap Tms (NASDAQ:EDAP) Coverage Initiated by Analysts at StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Edap Tms (NASDAQ:EDAP) in a research report issued to clients and investors on Saturday. The brokerage set a “hold” rating on the medical equipment provider’s stock.

A number of other brokerages have also commented on EDAP. HC Wainwright reissued a “buy” rating and set a $19.00 price objective on shares of Edap Tms in a report on Friday, March 28th. Jefferies Financial Group reiterated a “hold” rating and set a $2.00 price target (down previously from $8.00) on shares of Edap Tms in a research note on Friday. Finally, Piper Sandler reduced their price objective on shares of Edap Tms from $5.00 to $4.50 and set an “overweight” rating for the company in a research note on Friday, March 28th.

Edap Tms Price Performance

Shares of NASDAQ EDAP opened at $1.61 on Friday. Edap Tms has a twelve month low of $1.51 and a twelve month high of $8.50. The company has a quick ratio of 1.46, a current ratio of 2.18 and a debt-to-equity ratio of 0.08. The firm has a fifty day simple moving average of $2.39 and a 200 day simple moving average of $2.46. The company has a market capitalization of $59.74 million, a PE ratio of -2.48 and a beta of 0.37.

Edap Tms (NASDAQ:EDAP) last issued its earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.11) by $0.06. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. The business had revenue of $22.69 million for the quarter, compared to analyst estimates of $20.83 million. On average, sell-side analysts forecast that Edap Tms will post -0.6 EPS for the current year.

Hedge Funds Weigh In On Edap Tms

Several hedge funds and other institutional investors have recently added to or reduced their stakes in EDAP. Illumine Investment Management LLC purchased a new position in shares of Edap Tms during the 4th quarter valued at about $50,000. BNP Paribas Financial Markets boosted its holdings in Edap Tms by 23.7% in the third quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock valued at $59,000 after acquiring an additional 4,400 shares in the last quarter. Jane Street Group LLC lifted its holdings in Edap Tms by 174.7% in the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock worth $69,000 after buying an additional 73,361 shares during the period. Millennium Management LLC boosted its position in shares of Edap Tms by 218.5% during the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock valued at $108,000 after purchasing an additional 33,558 shares in the last quarter. Finally, Orion Capital Management LLC boosted its holdings in shares of Edap Tms by 10.4% during the 3rd quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock valued at $178,000 after buying an additional 6,600 shares in the last quarter. 62.74% of the stock is currently owned by hedge funds and other institutional investors.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.